نتایج جستجو برای: 177lu dotatate

تعداد نتایج: 1456  

Journal: :International journal of clinical and experimental medicine 2012
Matthias C Schmidt Klara Uhrhan Birgid Markiefka Laura Hasselbring Max Schlaak Birgit Cremer Sabine Kunze Richard P Baum Markus Dietlein

Herein, we report about two Caucasian patients with the histopathological diagnosis of Merkel cell carcinoma suffering from extensive lymph node metastases. The extent of the disease was diagnosed by Ga-68-DotaTATE-PET-CT. Both patients had rapid disease progression, one of them despite a three months course of sunitinibe followed by four chemotherapy cycles of cisplatin and etoposide. Both pat...

Journal: :Endocrine-related cancer 2017
Tessa Brabander Wouter A van der Zwan Jaap J M Teunissen Boen L R Kam Wouter W de Herder Richard A Feelders Eric P Krenning Dik J Kwekkeboom

Peptide receptor radionuclide therapy (PRRT) with [177Lu-DOTA0,Tyr3]octreotate (177Lu-DOTATATE) is a treatment with good results in patients with metastatic gastroenteropancreatic neuroendocrine tumours (GEPNETs). However, there are some pitfalls that should be taken into consideration when evaluating the treatment response after PRRT. 354 Dutch patients with GEPNETs who were treated with 177Lu...

Journal: :Journal of Nuclear Medicine Technology 2018

2017
Johan Gustafsson Anna Sundlöv Katarina Sjögreen Gleisner

BACKGROUND Dosimetry in radionuclide therapy has the potential to allow for a treatment tailored to the individual patient. One therapeutic radiopharmaceutical where patient-specific dosimetry is feasible is 177Lu-DOTATATE, used for the treatment of neuroendocrine tumours. The emission of gamma photons by 177Lu allows for imaging with SPECT (single photon emission computed tomography). One impo...

2016
Ho Sze Chan Mark W. Konijnenberg Tamara Daniels Monique Nysus Mehran Makvandi Erik de Blois Wouter A. Breeman Robert W. Atcher Marion de Jong Jeffrey P. Norenberg

BACKGROUND Targeted alpha therapy (TAT) offers advantages over current β-emitting conjugates for peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors. PRRT with 177Lu-DOTATATE or 90Y-DOTATOC has shown dose-limiting nephrotoxicity due to radiopeptide retention in the proximal tubules. Pharmacological protection can reduce renal uptake of radiopeptides, e.g., positively charged a...

Journal: :European Journal of Nuclear Medicine and Molecular Imaging 2011

Journal: :EJNMMI Physics 2021

Abstract Background Extravasation of radiopharmaceuticals used for vectorized internal radiotherapy can lead to severe tissue damage (van der Pol et al., Eur J Nucl Med Mol Imaging 44:1234–1243, 2017). Clinical management these extravasations requires the preliminary estimation dose distribution in extravasation area. Data are scarce regarding literature. This work presents a methodology estima...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید